Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of intensity-modulated radiotherapy with chemotherapy for stage III NSCLC
jRCTs042180119Completed
- Start
- Jan 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial in non-small cell lung cancer (NSCLC). Primary endpoint: Completion rate of treatment. Started Jan 2016; status: completed.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on jRCTs042180119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs042180119.